Search for: "Sandoz GmbH"
Results 41 - 60
of 68
Sorted by Relevance
|
Sort by Date
30 Dec 2016, 2:58 pm
Permission to appeal in patent cases - farewell to the Pozzoli approachGuest Kat Eibhlin Vardy recaps the case Teva UK Ltd v Boehringer Ingelheim Pharma GmbH & Co KG, [2016] EWCA Civ 1296. [read post]
12 Aug 2022, 6:48 pm
GmbH v. [read post]
17 Oct 2008, 1:32 pm
Proposed EU information laws on prescription drugs (IPmed) Iceland: Supplementary Protection Certificates (SPCs) in Iceland (The SPC blog) India: Roche implements 'mass serialisation' anti-counterfeiting technology (Spicy IP) Indonesia: Patent application on oil palm hybrids (navigating the patent maze) United States: New PMCA research: State legislative proposals restricting access to generic medicines would increase cost $29 billion over 10 years (GenericsWeb) US: Pharmaceutical… [read post]
18 Sep 2016, 6:03 pm
Amgen Inc., et al., No. 16-332 (effectively extending exclusivity to 12 1/2 years; complement to the Sandoz petition) Anticipation: Grunenthal GmbH v. [read post]
27 May 2010, 3:20 am
Sandoz Inc. [read post]
16 Jan 2017, 5:44 pm
Anticipation: Grunenthal GmbH v. [read post]
23 Sep 2022, 9:39 am
CALVET NV, HEMMAR PVC NV and URBAN GMBH & CO MASCHINENBAU KGAnother unmissable decision for this annual case law review is the judgment rendered by the Dutch-speaking Enterprise Court of Brussels on double patenting. [read post]
23 Feb 2015, 2:55 am
***** PREVIOUSLY, ON NEVER TOO LATE Never too late 33 [week ending Sunday 15 February] –- Evoking Audrey Hepburn’s image is not OK in Italy | Reasonable royalty and moral prejudice: new reference to the CJEU | CoA for England and Wales on parallel importations in Speciality European Pharma Ltd v Doncaster Pharmaceuticals Group Ltd & Madaus GmbH | The Logic of Innovation: Intellectual Property, and What the User Found There and Tritton on… [read post]
3 Mar 2015, 4:55 pm
Sandoz, Inc., No. 13-854, slip op. at 13 (Jan. 20, 2015). [read post]
8 Mar 2011, 1:23 pm
Sandoz, Inc., 566 F.3d 1282 (Fed. [read post]
13 May 2010, 4:58 pm
Sandoz, Inc. [read post]
6 Feb 2009, 5:00 am
Stem cell research under Obama (Ars Technica) US: Oxford Gene Technology settles legal action with Bioarray Solutions over patents covering use of microassays for detection of DNA sequence variations (Patent Docs) US: BPAI affirms rejection of claims to an isolated protein over prior art disclosing nucleic acid encoding the protein: Ex parte Chuang (not precedential) (Patent Docs) (Post-Grant) US: Supreme petitioned to grant certiorari in two cases important to biotech patenting: In re Bilski and… [read post]
3 Feb 2011, 8:39 am
The shipments of thiopental entering the U.S. originated from an Austrian facility owned by Sandoz International GmbH, a German company, according to the complaint. [read post]
28 Sep 2016, 8:39 am
Acorda Therapeutics, et al., No. 16-360 Anticipation: Grunenthal GmbH v. [read post]
13 Oct 2016, 6:50 am
Anticipation: Grunenthal GmbH v. [read post]
14 Nov 2016, 9:16 am
Petitions for Writ of Certiorari Denied or Dismissed: Anticipation: Grunenthal GmbH v. [read post]
8 Feb 2017, 3:09 am
Anticipation: Grunenthal GmbH v. [read post]
16 Feb 2015, 1:44 am
* "Fool's errand": no need to create your own brand if you can use someone else's Jeremy notes Speciality European Pharma Ltd v Doncaster Pharmaceuticals Group Ltd & Madaus GmbH [2015] EWCA Civ 54 [on which see earlier katpost here], a trade mark infringement decision of the Court of Appeal, England and Wales, on parallel importation and over-stickering of pharmaceutical products. [read post]
28 Mar 2012, 8:30 am
According to court filings, the shipments of thiopental entering the United States came from an Austrian facility owned by Sandoz International GmbH. [read post]
5 Oct 2020, 2:00 am
Standard Verlags GmbH, the Judge started by recalling that the "close connection" criteria requires the same situation of fact and law. [read post]
